Načítá se...

TMOD-25. GLIOBLASTOMA ORGANOIDS: A MODEL SYSTEM FOR PATIENT-SPECIFIC THERAPEUTIC TESTING

Glioblastoma treatment options remain limited due to its aggressive and invasive nature. It is increasingly appreciated that molecular heterogeneity between tumors and within tumors likely contributes to the lack of therapeutic advances. To maintain the inherent heterogeneity of glioblastoma, we emp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Salinas, Ryan, Zhang, Daniel, Jacob, Fadi, Nguyen, Phuong, Sheikh, Saad, Prokop, Stefan, Dorsey, Jay, Nasrallah, MacLean, Brem, Steven, O’Rourke, Donald, Ming, Guo-li, Song, Hongjun
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846667/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1124
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!